MA41188A - Compositions d'insuline à action rapide - Google Patents

Compositions d'insuline à action rapide

Info

Publication number: MA41188A
Authority: MA; Morocco
Prior art keywords: fast; acting insulin; insulin compositions; compositions; acting
Prior art date: 2014-12-16

Application number

MA041188A

Other languages

English (en)

Other versions

MA41188B1 (fr

Inventor

Michael Patrick Akers

Ranajoy Majumdar

Chi A Nguyen

Chad D Paavola

Virender Kumar Sarin

Nanette Elizabeth Schulte

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-12-16

Filing date

2015-12-09

Publication date

2017-10-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55066806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41188(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-12-09 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2017-10-24 Publication of MA41188A publication Critical patent/MA41188A/fr

2022-08-31 Publication of MA41188B1 publication Critical patent/MA41188B1/fr

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Zoology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MA41188A 2014-12-16 2015-12-09 Compositions d'insuline à action rapide MA41188B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201462092407P	2014-12-16	2014-12-16
PCT/US2015/064744 WO2016100042A1 (fr)	2014-12-16	2015-12-09	Compositions d'insuline à action rapide

Publications (2)

Publication Number	Publication Date
MA41188A true MA41188A (fr)	2017-10-24
MA41188B1 MA41188B1 (fr)	2022-08-31

Family

ID=55066806

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA41188A MA41188B1 (fr)	2014-12-16	2015-12-09	Compositions d'insuline à action rapide

Country Status (18)

Country	Link
US (4)	US9993555B2 (fr)
EP (2)	EP4108253A1 (fr)
JP (5)	JP6328855B2 (fr)
AR (1)	AR102869A1 (fr)
CY (1)	CY1125275T1 (fr)
DK (1)	DK3233108T3 (fr)
ES (1)	ES2911207T3 (fr)
HR (1)	HRP20220692T1 (fr)
HU (1)	HUE058764T2 (fr)
LT (1)	LT3233108T (fr)
MA (1)	MA41188B1 (fr)
MD (1)	MD3233108T2 (fr)
PL (1)	PL3233108T3 (fr)
PT (1)	PT3233108T (fr)
RS (1)	RS63174B1 (fr)
SI (1)	SI3233108T1 (fr)
TW (1)	TW201630622A (fr)
WO (1)	WO2016100042A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE032284T2 (en)	2008-03-18	2017-09-28	Novo Nordisk As	Protease-stabilized, acylated insulin analogues
CN104902922B (zh)	2012-11-13	2017-12-12	阿道恰公司	包含经取代阴离子化合物的速效胰岛素制剂
TW201630622A (zh) *	2014-12-16	2016-09-01	美國禮來大藥廠	速效胰島素組合物
JO3749B1 (ar)	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول
GB201607918D0 (en)	2016-05-06	2016-06-22	Arecor Ltd	Novel formulations
JP2019529506A (ja) *	2016-09-29	2019-10-17	アレコルリミテッド	新規の製剤
PE20210857A1 (es)	2016-12-16	2021-05-18	Novo Nordisk As	Composiciones farmaceuticas que contienen insulina
US20180236080A1 (en) *	2017-02-22	2018-08-23	Adocia	Fast-acting insulin composition comprising a citric acid salt
CA3056919A1 (fr) *	2017-03-26	2018-10-04	Vivi Robyn Stafford	Methode de traitement d'affections cutanees des paupieres
CN110662551B (zh) *	2017-06-01	2023-07-18	伊莱利利公司	速效胰岛素组合物
US20210113763A1 (en) *	2018-04-04	2021-04-22	Arecor Limited	Medical infusion pump system for the delivery of an insulin compound
US12357562B2 (en)	2018-04-04	2025-07-15	Arecor Limited	Injection pen system for the delivery of an insulin compound
KR102833828B1 (ko) *	2018-04-04	2025-07-15	아레콜 리미티드	인슐린 화합물의 전달을 위한 의료용 주입 펌프 시스템
FR3083985A1 (fr)	2018-07-23	2020-01-24	Adocia	Dispositif pour injecter une solution d'insuline(s)
WO2019243627A1 (fr)	2018-06-23	2019-12-26	Adocia	Dispositif pour injecter une solution d'insuline(s)
WO2020186154A1 (fr) *	2019-03-14	2020-09-17	The Regents Of The University Of California	Procédés et compositions pour la prise en charge de la santé rénale
US10639328B1 (en) *	2019-03-27	2020-05-05	College Of William & Mary	Compositions and methods for reducing hyperglycemia and treating diabetes
US10799564B1 (en)	2019-05-06	2020-10-13	Baxter International Inc.	Insulin premix formulation and product, methods of preparing same, and methods of using same
US20220354782A1 (en) *	2019-09-17	2022-11-10	Cass Pharmaceuticals, Inc.	Subcutaneously injectable insulin and glucagon formulations and methods of administration
EP4049032A1 (fr)	2019-10-25	2022-08-31	Cercacor Laboratories, Inc.	Composés indicateurs, dispositifs comprenant des composés indicateurs, et leurs procédés de fabrication et d'utilisation
IL296090A (en) *	2020-03-02	2022-11-01	Thermalin Inc	Compositions containing rapid-acting insulin analogues
GB202004814D0 (en)	2020-04-01	2020-05-13	Arecor Ltd	Novel formulations

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK116527B (da)	1967-03-01	1970-01-19	Nordisk Insulinlab	Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
DE3064888D1 (en)	1979-04-30	1983-10-27	Hoechst Ag	Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
FI78616C (fi)	1982-02-05	1989-09-11	Novo Industri As	Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
US4839341A (en) *	1984-05-29	1989-06-13	Eli Lilly And Company	Stabilized insulin formulations
PH25772A (en)	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
NO162160C (no)	1987-01-09	1989-11-15	Medi Cult As	Serumfritt vekstmedium, samt anvendelse derav.
IE62879B1 (en)	1987-02-25	1995-03-08	Novo Nordisk As	Novel insulin derivatives
US5716927A (en)	1988-12-23	1998-02-10	Novo Nordisk A/S	Insulin analogs having a modified B-chain
HUT56857A (en)	1988-12-23	1991-10-28	Novo Nordisk As	Human insulin analogues
US5474978A (en)	1994-06-16	1995-12-12	Eli Lilly And Company	Insulin analog formulations
US6258341B1 (en)	1995-04-14	2001-07-10	Inhale Therapeutic Systems, Inc.	Stable glassy state powder formulations
US5912014A (en)	1996-03-15	1999-06-15	Unigene Laboratories, Inc.	Oral salmon calcitonin pharmaceutical products
US5866538A (en)	1996-06-20	1999-02-02	Novo Nordisk A/S	Insulin preparations containing NaCl
AUPO066096A0 (en)	1996-06-26	1996-07-18	Peptide Delivery Systems Pty Ltd	Oral delivery of peptides
WO1999034821A1 (fr)	1998-01-09	1999-07-15	Novo Nordisk A/S	Compositions d'insuline stabilisees
WO2000043034A2 (fr)	1999-01-26	2000-07-27	Eli Lilly And Company	Formulations d'analogues d'insuline acyles hexameres monodisperses
EP1231907A2 (fr)	1999-11-15	2002-08-21	Hanamaraddi T. Gangal	Preparation de fluides a base de dextrose et d'insuline destinee a une infusion intraveineuse
JP4147234B2 (ja)	2004-09-27	2008-09-10	キヤノン株式会社	吐出用液体、吐出方法、カートリッジ及び吐出装置
US20020141946A1 (en)	2000-12-29	2002-10-03	Advanced Inhalation Research, Inc.	Particles for inhalation having rapid release properties
DE10114178A1 (de)	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de)	2002-06-18	2004-01-15	Aventis Pharma Deutschland Gmbh	Saure Insulinzubereitungen mit verbesserter Stabilität
ES2373660T3 (es) *	2003-11-13	2012-02-07	Novo Nordisk A/S	Composición farmacéutica que comprende un análogo insulinotrópico de glp-1 (7-37), insulina asp(b28) y un tensioactivo.
US7279457B2 (en)	2004-03-12	2007-10-09	Biodel, Inc.	Rapid acting drug delivery compositions
US20080090753A1 (en)	2004-03-12	2008-04-17	Biodel, Inc.	Rapid Acting Injectable Insulin Compositions
US8084420B2 (en)	2005-09-29	2011-12-27	Biodel Inc.	Rapid acting and long acting insulin combination formulations
US7713929B2 (en) *	2006-04-12	2010-05-11	Biodel Inc.	Rapid acting and long acting insulin combination formulations
WO2007041481A1 (fr)	2005-09-29	2007-04-12	Biodel, Inc.	Preparations d'insuline a action rapide et prolongee
EP2012817A2 (fr)	2006-04-12	2009-01-14	Biodel, Inc.	Formulations de combinaison d'insuline à action prolongée et à action rapide
US8084022B2 (en)	2006-06-23	2011-12-27	Aegis Therapeutics, Llc	Stabilizing alkylglycoside compositions and methods thereof
WO2008013955A2 (fr)	2006-07-27	2008-01-31	Nektar Therapeutics	Formulations à libération prolongée pour administration pulmonaire
JP5552046B2 (ja) *	2007-06-13	2014-07-16	ノボ・ノルデイスク・エー／エス	インスリン誘導体を含有する薬学的製剤
EP2036539A1 (fr)	2007-09-11	2009-03-18	Novo Nordisk A/S	Formulations stables d'amyline et ses analogues
TWI394580B (zh)	2008-04-28	2013-05-01	Halozyme Inc	超快起作用胰島素組成物
US9060927B2 (en)	2009-03-03	2015-06-23	Biodel Inc.	Insulin formulations for rapid uptake
US20120094902A1 (en)	2009-03-27	2012-04-19	Adocia	Fast-acting insulin formulation
FR2943538B1 (fr)	2009-03-27	2011-05-20	Adocia	Formulation a action rapide d'insuline recombinante humaine
KR101775000B1 (ko)	2009-06-26	2017-09-04	노보 노르디스크 에이/에스	인슐린, 니코틴아미드 및 아미노산을 포함하는 제제
CA2805031A1 (fr)	2010-07-07	2012-01-12	Biodel, Inc.	Compositions et procedes pour la modulation de la pharmacocinetique et de la pharmacodynamie de l'insuline
US20130011378A1 (en)	2011-06-17	2013-01-10	Tzung-Horng Yang	Stable formulations of a hyaluronan-degrading enzyme
NZ618331A (en) *	2011-06-17	2016-04-29	Halozyme Inc	Stable formulations of a hyaluronan-degrading enzyme
CA2839512C (fr)	2011-06-17	2018-01-02	Halozyme, Inc.	Procedes de perfusion d'insuline sous-cutanee continue utilisant une enzyme de degradation de l'hyaluronane
US20130231281A1 (en) *	2011-11-02	2013-09-05	Adocia	Rapid acting insulin formulation comprising an oligosaccharide
WO2013102144A2 (fr)	2011-12-30	2013-07-04	Halozyme, Inc.	Variants du polypeptide ph20, formulations en contenant et leurs utilisations
US9399065B2 (en) *	2012-04-16	2016-07-26	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en)	2012-04-16	2016-07-05	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
WO2013177565A1 (fr)	2012-05-25	2013-11-28	Amylin Pharmaceuticals, Llc	Compositions d'insuline/pramlintide et leurs procédés de fabrication et d'utilisation
CN104902922B (zh)	2012-11-13	2017-12-12	阿道恰公司	包含经取代阴离子化合物的速效胰岛素制剂
US20150065423A1 (en)	2013-08-30	2015-03-05	Perosphere, Inc.	Rapid acting injectable formulations
KR102351111B1 (ko)	2014-01-13	2022-01-14	써멀린 다이어비티즈, 엘엘씨	초속효성 인슐린 제형 및 약제학적 전달 시스템
WO2015120457A1 (fr)	2014-02-10	2015-08-13	Biodel Inc.	Formulations d'insuline à action ultrarapide stabilisées
US9795678B2 (en) *	2014-05-14	2017-10-24	Adocia	Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
TW201630622A (zh) *	2014-12-16	2016-09-01	美國禮來大藥廠	速效胰島素組合物
JO3749B1 (ar) *	2015-08-27	2021-01-31	Lilly Co Eli	تركيبات إنسولين سريعة المفعول

2015
- 2015-12-01 TW TW104140209A patent/TW201630622A/zh unknown
- 2015-12-01 AR ARP150103921A patent/AR102869A1/es unknown
- 2015-12-09 WO PCT/US2015/064744 patent/WO2016100042A1/fr not_active Ceased
- 2015-12-09 US US14/963,279 patent/US9993555B2/en active Active
- 2015-12-09 EP EP22164140.0A patent/EP4108253A1/fr active Pending
- 2015-12-09 LT LTEPPCT/US2015/064744T patent/LT3233108T/lt unknown
- 2015-12-09 MD MDE20170200T patent/MD3233108T2/ro unknown
- 2015-12-09 PL PL15817678T patent/PL3233108T3/pl unknown
- 2015-12-09 PT PT158176784T patent/PT3233108T/pt unknown
- 2015-12-09 JP JP2017531725A patent/JP6328855B2/ja active Active
- 2015-12-09 EP EP15817678.4A patent/EP3233108B1/fr active Active
- 2015-12-09 HR HRP20220692TT patent/HRP20220692T1/hr unknown
- 2015-12-09 HU HUE15817678A patent/HUE058764T2/hu unknown
- 2015-12-09 ES ES15817678T patent/ES2911207T3/es active Active
- 2015-12-09 SI SI201531823T patent/SI3233108T1/sl unknown
- 2015-12-09 RS RS20220416A patent/RS63174B1/sr unknown
- 2015-12-09 MA MA41188A patent/MA41188B1/fr unknown
- 2015-12-09 DK DK15817678.4T patent/DK3233108T3/da active
2018
- 2018-04-18 JP JP2018079985A patent/JP7093669B2/ja active Active
- 2018-05-14 US US15/978,329 patent/US11123406B2/en active Active
2020
- 2020-12-24 JP JP2020214703A patent/JP7159277B2/ja active Active
2021
- 2021-09-17 US US17/478,747 patent/US11872266B2/en active Active
2022
- 2022-05-11 CY CY20221100329T patent/CY1125275T1/el unknown
- 2022-10-12 JP JP2022163910A patent/JP2023011641A/ja active Pending
2023
- 2023-12-14 US US18/540,193 patent/US20240238382A1/en active Pending
2024
- 2024-11-15 JP JP2024199464A patent/JP2025032126A/ja active Pending

Also Published As

Publication number	Publication date
CY1125275T1 (el)	2024-12-13
SI3233108T1 (sl)	2022-05-31
EP3233108B1 (fr)	2022-03-30
US20160166695A1 (en)	2016-06-16
HUE058764T2 (hu)	2022-09-28
DK3233108T3 (da)	2022-04-11
JP2021073187A (ja)	2021-05-13
US11872266B2 (en)	2024-01-16
US20190231851A1 (en)	2019-08-01
HRP20220692T1 (hr)	2022-07-08
JP2018138578A (ja)	2018-09-06
RS63174B1 (sr)	2022-05-31
EP4108253A1 (fr)	2022-12-28
PT3233108T (pt)	2022-05-05
AR102869A1 (es)	2017-03-29
TW201630622A (zh)	2016-09-01
US20220072105A1 (en)	2022-03-10
MD3233108T2 (ro)	2022-09-30
US11123406B2 (en)	2021-09-21
JP2023011641A (ja)	2023-01-24
JP2025032126A (ja)	2025-03-11
US20240238382A1 (en)	2024-07-18
US9993555B2 (en)	2018-06-12
ES2911207T3 (es)	2022-05-18
JP6328855B2 (ja)	2018-05-23
JP7093669B2 (ja)	2022-06-30
WO2016100042A1 (fr)	2016-06-23
MA41188B1 (fr)	2022-08-31
EP3233108A1 (fr)	2017-10-25
JP2018500314A (ja)	2018-01-11
LT3233108T (lt)	2022-05-10
JP7159277B2 (ja)	2022-10-24
PL3233108T3 (pl)	2022-06-20

Publication	Publication Date	Title
ME03384B (fr)	2020-01-20	Compositions d'insuline à action rapide
MA41188A (fr)	2017-10-24	Compositions d'insuline à action rapide
MA42701A (fr)	2018-07-04	Compositions d'insuline à action rapide
DK3892302T3 (da)	2023-11-13	Sammensætninger indeholdende ibrutinib
MA42036A (fr)	2018-03-14	Analogues nucléosidiques 5'-substitués
LT3298027T (lt)	2021-08-10	Antihelmintiniai depsipeptido junginiai
PT3261437T (pt)	2019-11-29	Compostos e composições fungicidas
MA45727A (fr)	2019-05-29	Analogues de l'insuline
EP3363581A4 (fr)	2019-05-22	Composition d'assemblage
MA50496A (fr)	2020-09-09	Compositions d'insuline à action rapide
EP3245338C0 (fr)	2025-11-26	Dispositif d'endiguement
UA31878S (uk)	2016-04-11	Стіл-трансформер «sріdеr»
UA31879S (uk)	2016-04-11	Стіл-трансформер «маgnат»
UA32431S (uk)	2016-06-24	Стрем'янка
UA31297S (uk)	2016-01-12	Логотип «zlato cleaner»
UA31292S (uk)	2016-01-12	Логотип «маланка»
ITUB201551290U1 (it)	2017-01-06	Ovie' oviel
UA26982S (uk)	2014-05-12	Шеврон «рись»
UA32536S (uk)	2016-07-11	Логотип «нямушка»
UA29713S (uk)	2015-06-25	Пакувальний лист «буржуйские»
UA29710S (uk)	2015-06-25	Пакувальний лист «буржуйские»
UA29712S (uk)	2015-06-25	Пакувальний лист «буржуйские»
UA29711S (uk)	2015-06-25	Пакувальний лист «буржуйские»
UA31772S (uk)	2016-03-25	Етикетка «воронеж»
UA31997S (uk)	2016-04-25	Етикетка «карпатська»